In this study, we performed immunohistochemical staining for FRα expression in tumours to investigate the relationship between sFRα and tumour FRα status and to evaluate the possible application of sFRα testing in future clinical studies of FRα-targeted therapies. Here, FOLR1 is linked to neoplasm.